Strumento inattivo

Azioni DARA Biosciences Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

DARA BioSciences : Granted Waiver of Product and Establishment Fees by the FDA	08/01/15
DARA BioSciences : Announces Participation at the Aegis Capital Corporation Healthcare and Technology Conference in Las Vegas	16/09/14
DARA BioSciences : Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products	11/05/14
DARA BioSciences : Announces Addition of Soltamox(R), (Tamoxifen Citrate) Oral Solution, to the Authorized Federal Supply Schedule Price List	11/05/14

Settore

	Variaz. 1 gen.	Capi.
MERCK KGAA	+3,37%	69,25 Mrd
KYOWA KIRIN CO. LTD.	+12,55%	9 Mrd
SK BIOPHARMACEUTICALS CO., LTD.	-12,75%	4,96 Mrd
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+42,38%	4,47 Mrd
YUHAN CORPORATION	+5,23%	3,9 Mrd
INDIVIOR PLC	+20,31%	2,45 Mrd
BETTA PHARMACEUTICALS CO., LTD.	-19,05%	2,41 Mrd
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-28,72%	2,23 Mrd
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+11,13%	2,02 Mrd